EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma

Surgery is the only curative treatment for early-stage non-small cell lung cancer (NSCLC) patients. However, approximately one-third of these patients develop recurrence, which remains the main cause of mortality in the postsurgical treatment of NSCLC. Many molecular markers have been proposed to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Chi-Chen, Cheng, Wei-Chung, Huang, Yu-Chuen, Sher, Yuh-Pyng, Liou, Nia-Jhen, Chien, Yu-Chuan, Lin, Pei-Shan, Lin, Pei-Syuan, Chen, Chung-Hsuan, Chang, Wei-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668280/
https://www.ncbi.nlm.nih.gov/pubmed/29097801
http://dx.doi.org/10.1038/s41598-017-15186-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668280/
https://www.ncbi.nlm.nih.gov/pubmed/29097801
http://dx.doi.org/10.1038/s41598-017-15186-y

Ejemplares similares